-
Study aim
-
Determination and between-groups comparison of the mean FEV1, FVC, FEV1 / FVC, PEF, IL13, blood eosinophil percentage, and mean baseline asthma test (pre-test)
• Determination and between-groups comparison of the mean FEV1, FVC, and other variables at post-test.
• Determination and within-group comparison of the mean FEV1, FVC, and other variables in the study groups.
-
Design
-
Randomized clinical trial with control group, single-blind and parallel groups, phase 3 with 120 patients
-
Settings and conduct
-
120 eligible patients who will be referred to Shahid Mofteh Yasuj Children's Clinic will be examined. In the baseline, the dependent variables will be examined in the study groups and, after the intervention, the outcome variables will be measured again and compared in the groups.
-
Participants/Inclusion and exclusion criteria
-
Patients aged 10 - 18 years
A well-known case of persistent moderate asthma
All patients are taking fluticasone spray.
No history of other respiratory illnesses
Exclusion :
• Immigration or death
• Dissatisfaction with continuing the treatment.
• In case of other infectious or chronic diseases during the research
-
Intervention groups
-
Intervention group 1. Lactobacillus Rhamnosus will be given 10 drops of this probiotic.
Intervention group 2. Lactobacillus Ruteri 5 drops will be given daily and orally.
Intervention group 3. The combined group will be given 10 drops of Lactobacillus Rhamnosus along with 5 drops of Lactobacillus Ruteri orally.
Control group: For the control group, in the same color and similar glasses containing distilled water and orange essential oil, 10 and 5 drops will be given orally and daily.
-
Main outcome variables
-
Reduce asthma attacks, improving spirometry parameters